According to Bio-Techne's latest financial reports the company has a price-to-book ratio of 5.56.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 6.21 | -12.72% |
2022-12-31 | 7.12 | -40.37% |
2021-12-31 | 11.9 | 49.09% |
2020-12-31 | 8.01 | 26.12% |
2019-12-31 | 6.35 | 27.49% |
2018-12-31 | 4.98 | 2.4% |
2017-12-31 | 4.86 | 12.9% |
2016-12-31 | 4.31 | 10.21% |
2015-12-31 | 3.91 | -6.45% |
2014-12-31 | 4.18 | -10.47% |
2013-12-31 | 4.67 | 28.75% |
2012-12-31 | 3.63 | -14.24% |
2011-12-31 | 4.23 | -6.02% |
2010-12-31 | 4.50 | -13.98% |
2009-12-31 | 5.23 | -9.1% |
2008-12-31 | 5.75 | 4.03% |
2007-12-31 | 5.53 | -2.42% |
2006-12-31 | 5.67 | -26.33% |
2005-12-31 | 7.69 | 59.03% |
2004-12-31 | 4.84 | -17.16% |
2003-12-31 | 5.84 | 10.83% |
2002-12-31 | 5.27 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 4.72 | -15.13% | ๐บ๐ธ USA |
Becton Dickinson BDX | 2.81 | -49.41% | ๐บ๐ธ USA |
General Electric GE | 6.89 | 23.98% | ๐บ๐ธ USA |
Danaher DHR | 3.44 | -38.10% | ๐บ๐ธ USA |
Qiagen QGEN | 2.49 | -55.28% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | 0.9192 | -83.46% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 1.14 | -79.57% | ๐บ๐ธ USA |